Metacrine – San Diego, 6.5 million shares, priced $12-$14, managed by Jefferies/Evercore ISI. Proposed Nasdaq symbol MTCR. Business: Phase 1 biotech developing FXR agonist therapies for NASH.
Outset Medical – San Jose, Calif., 7.6 million shares, priced $22-$24, managed by BofA Securities/Morgan Stanley. Proposed Nasdaq symbol OM. Business: Provides a hemodialysis system for kidney diseases.
Pactiv Evergreen – Lake Forest, Ill., 41 million shares, priced $18-$21, managed by Credit Suisse/Citi. Proposed Nasdaq symbol PTVE. Business: Manufacturer of fresh food and beverage packaging in North America.
Palantir – Denver, Colo., 244.2 million shares, priced at $11.50, managed by Morgan Stanley/Credit Suisse. Proposed NYSE symbol PLTR. Business: Data analytics platform focused on the government and financial.
Snowflake – San Mateo, Calif., 28 million shares, priced $75-$85, managed by Goldman Sachs/Morgan Stanley. Proposed NYSE symbol SNOW. Business: Provides a cloud-based data warehousing platform.
StepStone Group – New York, 17.5 million shares, priced 15-$17, managed by JP Morgan/Goldman Sachs. Proposed Nasdaq symbol STEP. Business: Global private markets investment firm.
Sumo Logic – Redwood City, Calif., 14.8 million shares, priced $17-$21, managed by Morgan Stanley/JP Morgan. Proposed Nasdaq symbol SUMO. Business: Provides on-demand cloud log management solutions to enterprises.